CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children.
Ching-Hui TsaiAnn Chen WuBor-Luen ChiangYao-Hsu YangShih-Pin HungMing-Wei SuYa-Jen ChangYungling Leo LeePublished in: Thorax (2020)
rs7251960 is an eQTL for CEACAM3, and CEACAM3 mRNA expression is reduced in subjects experiencing asthma exacerbations. CEACAM3 may be a modulator of RSV latent infection on asthma exacerbations.